Multi-phase hybrid metabolomics framework identifies clinically applicable plasma signatures for early detection of gastric cancer

Journal:

Nature Communications

Published:

2026-05-13

DOI:

10.1038/s41467-026-72983-8

Affiliations:

9

Authors:

10

Go to article

Institutions	Authors	Share
Wuhan Metware Biotechnology Co., Ltd., China	4.000000	0.40
Beijing Friendship Hospital, Capital Medical University, China	2.300000	0.23
Tongji Hospital (TJH), HUST, China	1.000000	0.10
Renmin Hospital of Wuhan University/Hubei General Hospital, China	1.000000	0.10
Cancer Institute and Hospital, CAMS & PUMC, China	1.000000	0.10
State Key Laboratory of Digestive Health, Capital Medical University, China	0.700000	0.07

Interested in Bioinformatics and Computational Biology?